VOTE AGAINST RESOLUTION 1!, page-173

Remember that I have been around BIT (as a shareholder and now not a shareholder) for 10 years.

BIT has always has tremendous potential - though they are guilty of self promotion on a number of times.

OK - now it gets down to the nitty gritty - timing.

Be aware that several antivirals are being developed to cater for COVID - BIT is not alone in that field.

There is certainly a great deal of passion and optimism for BIT by holders here - and there is nothing wrong with anyone not being positive about their investment - otherwise, why hold at all? Passion alone will not do te job though - positive trial results and commercial partnerships will.

HepB and, more importantly, HIV treatments have been promised for a decade now as "cures". As a Biotech, BIT may get the award for the slowest Biotech company developing products after they announced success.

So, original question stands - are we talking 3 or 6 months for success - and, if that time frame, what the basis of that? CEO's address is just that - and she will only say something positive as she is presenting the company to investors.

Timing is everything so when will BIT get something brilliant?